Eric Karas
2022
In 2022, Eric Karas earned a total compensation of $222.6K as Chief Commercial Officer at ARS Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $147,600 |
|---|---|
| Salary | $68,333 |
| Other | $6,691 |
| Total | $222,624 |
Karas received $147.6K in non-equity incentive plan, accounting for 66% of the total pay in 2022.
Karas also received $68.3K in salary and $6.7K in other compensation.
Rankings
In 2022, Eric Karas' compensation ranked 5,334th out of 5,760 executives tracked by ExecPay. In other words, Karas earned more than 7.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,334 out of 5,760 | 7th |
Division Manufacturing | 2,922 out of 3,136 | 7th |
Major group Chemicals And Allied Products | 1,354 out of 1,422 | 5th |
Industry group Drugs | 1,267 out of 1,323 | 4th |
Industry Pharmaceutical Preparations | 924 out of 969 | 5th |
Source: SEC filing on May 1, 2023.
Karas' colleagues
We found six more compensation records of executives who worked with Eric Karas at ARS Pharmaceuticals in 2022.
2022
Laura Shawver
ARS Pharmaceuticals
Chief Executive Officer
2022
Valerie Odegard
ARS Pharmaceuticals
Chief Scientific Officer
2022
Jonathan Piazza
ARS Pharmaceuticals
Chief Financial Officer
2022
Jeffrey Pepe
ARS Pharmaceuticals
Chief Executive Officer
2022
Richard MSEL
ARS Pharmaceuticals
Chief Executive Officer
2022
Sarina Tanimoto
ARS Pharmaceuticals